Rainbow Childrens Medicare files SEBI Regulation 31(4) takeover disclosure with NSE
Rainbow Childrens Medicare Limited, a healthcare chain operator listed on NSE, submitted a Regulation 31(4) disclosure to NSE on 1–3 July 2026 under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This is a mandatory filing triggered by acquisition or change in substantial shareholding (typically ≥5%). The disclosure document lodged with the exchange contains the identity of the acquiring party, number of shares acquired, acquisition price, and relevant exemptions or conditions under the takeover code. Full transaction terms require review of the actual disclosure PDF.
Why it mattersRegulation 31(4) disclosures are mandatory within 4 trading days of substantial shareholding (>=5%) acquisition or change; this filing triggers review of open offer obligations, exemptions under Rule 3(d) (group entity / inter-se transfers), and potential takeover code compliance pathways.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives - SEBI Takeover Regulations Disclosure (PDF) · official
- NSE Corporate Actions Portal · official
- SEBI - Takeover Regulations & Guidance · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Time Technoplast Board Approves ₹50 Cr Equity Investment in Time Intercontinental26 Aug 2026 · ₹50 cr
- Mankind Pharma Limited: Other Restructuring26 Aug 2026